Alnylam Pharmaceuticals, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

68,049

Value ($000)

27,032

Weight

0.0%

2013 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	27,032	0.0%	68,049	12/31/2025
2025 Q2	8/13/2025	2,798	0.0%	8,580	6/30/2025
2025 Q1	5/13/2025	7,459	0.0%	27,783	3/31/2025
2024 Q4	2/12/2025	5,483	0.0%	23,230	12/31/2024
2024 Q3	11/13/2024	13,015	0.0%	47,342	9/30/2024
2024 Q2	8/12/2024	13,784	0.0%	56,724	6/30/2024
2024 Q1	5/14/2024	13,286	0.0%	88,902	3/31/2024
2023 Q4	2/14/2024	8,513	0.0%	44,475	12/31/2023
2023 Q3	11/14/2023	1,356	0.0%	7,655	9/30/2023
2023 Q2	8/11/2023	1,558	0.0%	8,203	6/30/2023
2023 Q1	5/11/2023	1,776	0.0%	8,864	3/31/2023
2022 Q4	2/10/2023	2,015	0.0%	8,480	12/31/2022
2022 Q3	11/14/2022	1,817	0.0%	9,078	9/30/2022
2022 Q2	8/11/2022	1,575	0.0%	10,823	6/30/2022
2022 Q1	5/16/2022	1,641	0.0%	9,932	3/31/2022
2021 Q4	2/14/2022	968	0.0%	5,711	12/31/2021
2021 Q3	11/12/2021	935	0.0%	4,953	9/30/2021
2021 Q2	8/13/2021	789	0.0%	4,656	6/30/2021
2021 Q1	5/28/2021	529	0.0%	3,745	3/31/2021
2020 Q4	2/16/2021	487	0.0%	3,745	12/31/2020
2020 Q3	11/13/2020	508	0.0%	3,745	9/30/2020
2020 Q2	8/13/2020	524	0.0%	3,539	6/30/2020
2020 Q1	5/15/2020	225	0.0%	2,005	3/31/2020
2014 Q1	5/15/2014	1,082	0.0%	16,112	3/31/2014
2013 Q4	2/14/2014	1,402	0.0%	21,807	12/31/2013